Dr. Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Abbott Laboratories(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Boston Scientific(MODEST), PHILIPS/Spectranetics(MODEST), Rx Worldwide Roivant Sciences(MODEST), Merck & Co., Inc.(MODEST), BIOSENSORS(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Daiichi Sankyo(MODEST), philips/volcano(SIGNIFICANT), Siemens(MODEST), Sanofi-Aventis(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(MODEST) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), Bristol-Myers Squibb Company (MODEST), CSL Behring (SIGNIFICANT), Abbott Laboratories(SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Claret Medical(SIGNIFICANT), Elixir Medical(MODEST), Janssen Pharmaceuticals, Inc(MODEST), CONTROLRAD(MODEST)

View Full Disclosure